CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+18.02%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$1.06B
AUM Growth
+$1.06B
(-1.1%)
Cap. Flow
-$150M
Cap. Flow
% of AUM
-14.08%
Top 10 Holdings %
Top 10 Hldgs %
37.54%
Holding
501
New
15
Increased
263
Reduced
171
Closed
24
Top Buys
| 1 |
SPDR Gold Trust
GLD
|
$6.59M |
| 2 |
iShares Gold Trust Micro
IAUM
|
$4.62M |
| 3 |
Intuit
INTU
|
$3.73M |
| 4 |
SPDR Gold MiniShares Trust
GLDM
|
$3.6M |
| 5 |
T-Mobile US
TMUS
|
$2.35M |
Top Sells
| 1 |
Apple
AAPL
|
$17.4M |
| 2 |
NVIDIA
NVDA
|
$12.2M |
| 3 |
Microsoft
MSFT
|
$11.5M |
| 4 |
Amazon
AMZN
|
$8.86M |
| 5 |
Broadcom
AVGO
|
$8.43M |
Sector Composition
| 1 | Technology | 38.15% |
| 2 | Healthcare | 22.68% |
| 3 | Communication Services | 12.64% |
| 4 | Consumer Discretionary | 11.62% |
| 5 | Consumer Staples | 3.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Castle Biosciences
CSTL
$702M
| $118K | 0.01% |
5,799
+80
| +1% | +$1.63K |
|
352
Personalis
PSNL
$427M
| $116K | 0.01% |
17,740
+36
| +0.2% | +$236 |
|
353
Iovance Biotherapeutics
IOVA
$792M
| $115K | 0.01% |
67,069
+1,303
| +2% | +$2.24K |
|
354
Amylyx Pharmaceuticals
AMLX
$890M
| $115K | 0.01% |
17,904
+716
| +4% | +$4.59K |
|
|
SAGE
355
DELISTED
Sage Therapeutics
SAGE
| $115K | 0.01% |
12,577
+245
| +2% | +$2.23K |
|
356
KalVista Pharmaceuticals
KALV
$719M
| $113K | 0.01% |
9,985
+73
| +0.7% | +$825 |
|
357
Xencor
XNCR
$610M
| $112K | 0.01% |
14,294
+161
| +1% | +$1.27K |
|
358
Trevi Therapeutics
TRVI
$885M
| $112K | 0.01% |
20,435
+2,510
| +14% | +$13.7K |
|
359
Tango Therapeutics
TNGX
$741M
| $111K | 0.01% |
21,771
+86
| +0.4% | +$440 |
|
360
Theravance Biopharma
TBPH
$697M
| $111K | 0.01% |
10,043
+179
| +2% | +$1.97K |
|
361
Keros Therapeutics
KROS
$638M
| $109K | 0.01% |
8,157
+21
| +0.3% | +$280 |
|
362
Arvinas
ARVN
$580M
| $108K | 0.01% |
14,660
+866
| +6% | +$6.37K |
|
363
MeiraGTx Holdings
MGTX
$587M
| $105K | 0.01% |
16,141
+465
| +3% | +$3.03K |
|
364
Phibro Animal Health
PAHC
$1.49B
| $104K | 0.01% |
4,091
+12
| +0.3% | +$306 |
|
365
abrdn Physical Silver Shares ETF
SIVR
$2.52B
| $103K | 0.01% |
3,000
| – | – |
|
366
Tyra Biosciences
TYRA
$668M
| $102K | 0.01% |
10,681
+531
| +5% | +$5.08K |
|
367
Kura Oncology
KURA
$690M
| $100K | 0.01% |
17,388
+1,190
| +7% | +$6.87K |
|
|
MESO
368
Mesoblast
MESO
$1.68B
| $99.4K | 0.01% |
9,124
+2,302
| +34% | +$25.1K |
|
369
MindMed
MNMD
$695M
| $98.5K | 0.01% |
15,175
+466
| +3% | +$3.02K |
|
370
Zevra Therapeutics
ZVRA
$511M
| $96.8K | 0.01% |
10,982
+276
| +3% | +$2.43K |
|
371
HUTCHMED
HCM
$2.63B
| $93.8K | 0.01% |
6,230
+9
| +0.1% | +$135 |
|
372
SIGA Technologies
SIGA
$618M
| $93.6K | 0.01% |
14,349
+26
| +0.2% | +$170 |
|
|
AUTL
373
Autolus Therapeutics
AUTL
$375M
| $91.8K | 0.01% |
40,273
+73
| +0.2% | +$166 |
|
374
Fortrea Holdings
FTRE
$909M
| $89.8K | 0.01% |
18,177
+185
| +1% | +$914 |
|
375
Cullinan Oncology
CGEM
$442M
| $89.3K | 0.01% |
11,853
+116
| +1% | +$873 |
|